Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Join our community Expert content, healing insights and free webinar invitations
This helps your body to increase insulin levels and control blood sugar levels
The maker of Wegovy and Ozempic, Novo Nordisk, has predicted a sharp drop in revenues this year owing to what its boss described as a painful push by Donald Trump to lower US weight-loss drug prices, rising competition, and the loss of important patent protections
The tablet was approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) in June 2026, making it the first GLP-1 tablet licensed specifically for weight loss in the UK
The endpoint there was half-life
US$ 29.56
US$ 27.28
US$ 24.54
US$ 25.13
US$ 27.85
US$ 24.27
